ABSTRACT. Objective. To assess whether, in girls with early onset of puberty, low birth weight is a risk factor for rapid progression to menarche and for short adult stature.
N owadays, puberty starts in girls at a younger age than in previous generations; for example, in the United States, onset of breast development occurs at a mean age of 10.0 years. 1, 2 If pubertal development starts before the age of 6 to 7 years, there is consensus that an evaluation is warranted, in part, because of the risk for early menarche and short final height. These risks seem to be no longer relevant when the onset of puberty occurs after the age of 9 years, because an earlier onset after that age is usually compensated by a slower rate of pubertal progression. 3 Current debate thus focuses on early/normal puberty starting at ϳ7 to 8 years of age, a specific question being whether there is a subgroup that may, nevertheless, be at risk for early menarche and reduced final height. On a quantitative basis, the latter question is primarily relevant for girls starting puberty at 8 years of age and, in particular, for those having rather short parents.
We hypothesized that, among the girls with early/ normal onset of puberty, those with a low birth weight may be at risk for rapid progression and for reduced final height. This hypothesis was based on the previous identification of low birth weight in girls as a risk factor for subsequent short stature, exaggerated adrenarche, and ovarian dysfunction. 4 -6 We have now tested this hypothesis in a cohort of girls with onset of puberty at 8 years of age.
METHODS
The study population consisted of all 54 Catalan (Northern Spanish) girls with early/normal onset of breast development, who had been followed up to final height in the Pediatric Endocrine Unit of Barcelona (Barcelona, Spain) over the past decade (1986 -1997) . At that time, it was estimated that Ͻ4% to 6% of Catalan girls experienced onset of puberty before 9 years of age. 3 The diagnosis of early/normal puberty was made on referral and was based on: 1) onset of breast development (with or without pubarche) between 8.0 and 9.0 years of age and within the preceding 3 to 6 months 7, 8 ; 2) uterine corpus length Ͼ40 mm on ultrasound examination 9 ; and 3) peak plasma luteinizing hormone Ͼ8 UI/L in response to gonadotropin-releasing hormone. 10 Height was measured with a Harpenden (Wima Technik AG, Rapperswil, Switzerland) stadiometer and transformed into standard deviation (SD) scores according to Tanner references, 11 which were appropriate for Catalan children over the time span of follow-up. 12 Final height was considered to be reached when postmenarcheal growth velocity had decreased to Ͻ.5 cm/year and/or when bone age was Ն15.0 years.
Birth weight and gestational age data were obtained from hospital records and transformed into SD scores for gestational age, as described 13 ; the population was divided into normal and low birth weight subgroups according to a cutoff level of Ϫ1.5 SD (ϳ 2.7 kg at term birth), a level of prenatal growth restriction that is associated with subsequent ovarian hyperandrogenism and hyperinsulinism in girls with a history of precocious pubarche. 13 Target height was defined as midparental height adjusted for female gender. Bone age was assessed by a single observer, according to the method of Greulich and Pyle. 14 Data are expressed as mean Ϯ standard error of the mean; t tests were used for comparisons with P values Ͻ.05 considered statistically significant. Table 1 summarizes the clinical variables observed in the study population at birth, at time of diagnosis, at menarche, and at final height.
RESULTS
Overall, the cohort was found to have a relatively low birth weight SD score of Ϫ.6 Ϯ .1 (mean weight: ϳ3.1 kg at term birth) and also a low target height SD score of Ϫ.9 Ϯ .1 (mean height: 156.6 Ϯ .7 cm). In line with previous reports, the average bone age was advanced at the time of diagnosis, mean age at menarche was normal, 3, 12 and the final height was at target level.
Subdividing the cohort according to birth weight revealed that the target heights of the 2 subgroups were comparable, as were their characteristics at diagnosis of early puberty. Thereafter, however, major differences between the subgroups were disclosed: girls with a lower birth weight (mean weight: ϳ2.5 kg at term birth) experienced menarche, on average, 1.6 years earlier, and their mean final height was reduced by Ͼ5 cm.
DISCUSSION
Whether girls with early onset of puberty have a normal timing of menarche and reach target height was found to depend on their prenatal growth status, as assessed by birth weight for gestational age.
If prenatal growth was not reduced, then girls with an onset of puberty at 8 years of age seem to progress, on average, slowly through puberty and to experience a normal timing of menarche. Hence, our findings in these girls extend the principle applicable to girls with pubertal onset after 9 years of age, namely that an earlier onset of breast development is followed by a longer interval to menarche. 3 In contrast, if prenatal growth was reduced, then girls with onset of puberty at 8 years of age were found to experience menarche early and to have a reduced final height. Thus, these girls seem to be incompletely protected by the aforementioned mechanism that compensates an early onset of puberty by a slower progression to menarche and by a longer duration of the pubertal growth spurt. The sequence of low birth weight, early and rapidly progressive puberty, and short adult stature has recently been noted in girls with uniparental disomy of chromosome 14. 15 It remains to be verified to which extent the failure of the compensatory mechanism in these girls is orchestrated by changes in hypothalamopituitary function and/or by altered target organ responsiveness to hormonal stimulation by, for example, follicle-stimulating hormone, insulin, and growth hormone. 5,16 -20 Regardless of the mechanisms that will prove to be involved, if the described acceleration of menarche and the reduction of final height are perceived as clinically relevant and are confirmed in other ethnic and/or larger groups, then girls with the combination of low birth weight and early onset of puberty may be the subgroup that is most likely to benefit from any therapeutic intervention aimed at a delay of pubertal development and/or an increase of final height. Henceforth, these observations may also be relevant when interpreting the effect of gonadotropin-releasing hormone-analog treatment on the final height of girls with early onset of puberty, or when judging the effect of GH treatment on the pubertal progression of girls with short stature after prenatal growth restriction. 
